| LDR | | 02058nam u200637 4500 |
| 001 | | 000000486174 |
| 005 | | 20230213152318 |
| 008 | | 230117s2022 |||||||||||||||||c||eng d |
| 020 | |
▼a 9798357513052 |
| 035 | |
▼a (MiAaPQ)AAI29756352 |
| 040 | |
▼a MiAaPQ
▼c MiAaPQ
▼d 247004 |
| 082 | 0 |
▼a 300 |
| 100 | 1 |
▼a Horowitz, Nina Beryl. |
| 245 | 10 |
▼a Engineering a Robust and Scalable Platforn for the Production of IEILC1-Like Nk Cells, a Novel Solid Tumor Immunothereapeutic Modality. |
| 260 | |
▼a [S.l.]:
▼b Stanford University.,
▼c 2022. |
| 260 | 1 |
▼a Ann Arbor:
▼b ProQuest Dissertations & Theses,
▼c 2022. |
| 300 | |
▼a 119 p. |
| 500 | |
▼a Source: Dissertations Abstracts International, Volume: 84-05, Section: B. |
| 500 | |
▼a Advisor: Barron, Annelise E. ;Engleman, Edgar G. ;Sunwoo, John. |
| 502 | 1 |
▼a Thesis (Ph.D.)--Stanford University, 2022. |
| 506 | |
▼a This item must not be sold to any third party vendors. |
| 590 | |
▼a School code: 0212. |
| 650 | 4 |
▼a Patients. |
| 650 | 4 |
▼a Metastasis. |
| 650 | 4 |
▼a Antibodies. |
| 650 | 4 |
▼a Immunotherapy. |
| 650 | 4 |
▼a Cytotoxicity. |
| 650 | 4 |
▼a Cancer therapies. |
| 650 | 4 |
▼a Immune system. |
| 650 | 4 |
▼a Cytokines. |
| 650 | 4 |
▼a Response rates. |
| 650 | 4 |
▼a Medical research. |
| 650 | 4 |
▼a Clinical trials. |
| 650 | 4 |
▼a Lymphocytes. |
| 650 | 4 |
▼a Antigens. |
| 650 | 4 |
▼a Tumors. |
| 650 | 4 |
▼a Lymphoma. |
| 650 | 4 |
▼a Immunocompetence. |
| 650 | 4 |
▼a Protein expression. |
| 650 | 4 |
▼a Cellular biology. |
| 650 | 4 |
▼a Immunology. |
| 650 | 4 |
▼a Oncology. |
| 650 | 4 |
▼a Pharmaceutical sciences. |
| 690 | |
▼a 0379 |
| 690 | |
▼a 0982 |
| 690 | |
▼a 0992 |
| 690 | |
▼a 0572 |
| 710 | 20 |
▼a Stanford University. |
| 773 | 0 |
▼t Dissertations Abstracts International
▼g 84-05B. |
| 773 | |
▼t Dissertation Abstract International |
| 790 | |
▼a 0212 |
| 791 | |
▼a Ph.D. |
| 792 | |
▼a 2022 |
| 793 | |
▼a English |
| 856 | 40 |
▼u http://www.riss.kr/pdu/ddodLink.do?id=T16620900
▼n KERIS
▼z 이 자료의 원문은 한국교육학술정보원에서 제공합니다. |
| 980 | |
▼a 202302
▼f 2023 |
| 990 | |
▼a ***1012033 |
| 991 | |
▼a E-BOOK |